- Club news. Hediger, Jim // Model Railroader;Jan98, Vol. 65 Issue 1, p60
Presents news briefs on train clubs throughout Canada and the United States. Included the destruction of the Central Indiana Ntrak Club (CINtrak) by fire on October 21, 1997; Creation of a homepage that advertise all the train clubs in Ottawa; Cancellation of the 1997 open house.
- A foot in the door. Paul, Reld // Pharmaceutical Representative;Sep2008, Vol. 38 Issue 9, p3
The author reflects on the revised PhRMA code for the pharmaceutical industry in the U.S. He states that the code is one of the most visible steps that the pharmaceutical industry has taken in some time to improve reputation. He adds that critics are quick to point out that the voluntary rules...
- The Changing Industry-Practitioner Relationship. Sussman, Norman // Primary Psychiatry;Dec2008, Vol. 15 Issue 12, p22
Generations of physicians have been accustomed to receiving pens, pads, mugs, and assorted models of the spine, the brain, and other organs, all courtesy of pharmaceutical and medical device manufacturers. Most, if not all, of these gifts will cease as of January 2009, when a new guideline for...
- The Pharmaceutical Research and Manufacturers of America (PhRMA), Amicus Curiae. Calia, Kurt G. // Supreme Court Debates;Sep2013, Vol. 16 Issue 6, p28
An excerpt from the Amicus Curiae Brief for Respondents that was submitted to the U.S. Supreme Court in March 2013, involving the Pharmaceutical Research and Manufacturers of America (PhRMA), is presented.
- Building a Healthcare System. Tauzin, Billy // Vital Speeches of the Day;4/1/2006, Vol. 72 Issue 12, p378
This article presents a speech given by Billy Tauzin, president and CEO of PhRMA, delivered to the 2006 Annual Membership Meeting, at the American Tort Reform Association, in Washington, D.C., on March 22, 2006. Tauzin discusses how the PhRMA's safety record and how the pharmaceutical industry...
- Robust Cancer Pipeline. // Pharmaceutical Representative;May2011, Vol. 41 Issue 5, p8
The article accounts on the report released by the Pharmaceutical Research and Manufacturers of America (PhRMA) regarding the 900 therapies for the treatment, prevention, or diagnosis of cancer that are currently in development, which is more than double the number of therapies six years ago.
- WHAT FINANCIAL SERVICES NEEDS TO LEARN FROM PHARMA. // Financial & Insurance Meetings;Jul/Aug2008, Vol. 44 Issue 4, p34
The article deals with the lessons the financial services industry needs to learn from the crisis faced by the U.S. pharmaceutical industry in 2002. The pharmaceutical industry was widely vilified for providing doctors free meals, entertainment and travel. In response, the Pharmaceutical...
- Free gifts to health care professionals now a no-no. BASSETT, ELIZABETH // Fort Worth Business Press;1/26/2009, Vol. 21 Issue 3, p21
The article reports on the revision of Pharmaceutical Research and Manufacturers of America's voluntary Code on Interactions with Healthcare Professionals which prohibits handing out non-educational reminders to health care professionals. The reason behind the revision is the tendency of such...
- The Web. // Pharmaceutical Representative;Mar2008, Vol. 38 Issue 3, p13
The article reviews the web sites related to medical research which includes sharingmiracles.com of Pharmaceutical Research and Manufacturers of America and jr2.ox.ac.uk of Oxford University.